Prospective Randomized Trial of Biologic Augmentation With Bone Marrow Aspirate Concentrate in Patients Undergoing Arthroscopic Rotator Cuff Repair
The American Journal of Sports Medicine · 2023-04 · 51 (5) · 1234-1242
DOI: 10.1177/03635465231154601 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The American Journal of Sports Medicine, online erschienen am 22.02.2023. Verfasst von Brian J Cole und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Sports Medicine, Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Rotator Cuff Injuries, Biological Products. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
Although initial studies have demonstrated that concentrated bone marrow aspirate (cBMA) injections promote rotator cuff repair (RCR) healing, there are no randomized prospective studies investigating clinical efficacy. Hypothesis/Purpose: To compare outcomes after arthroscopic RCR (aRCR) with and without cBMA augmentation. It was hypothesized that cBMA augmentation would result in statistically significant improvements in clinical outcomes and rotator cuff structural integrity. Study Design: Randomized controlled trial; Level of evidence, 1.
Methods
Patients indicated for aRCR of isolated 1- to 3-cm supraspinatus tendon tears were randomized to receive adjunctive cBMA injection or sham incision. Bone marrow was aspirated from the iliac crest, concentrated using a commercially available system, and injected at the aRCR site after repair. Patients were assessed preoperatively and serially until 2 years postoperatively via the following functional indices: American Shoulder and Elbow Surgeons (ASES), Single Assessment Numeric Evaluation (SANE), Simple Shoulder Test, 12-Item Short Form Health Survey, and Veterans RAND 12-Item Health Survey. Magnetic resonance imaging (MRI) was performed at 1 year to assess rotator cuff structural integrity according to Sugaya classification. Treatment failure was defined as decreased 1- or 2-year ASES or SANE scores as compared with preoperative baseline, the need for revision RCR, or conversion to total shoulder arthroplasty.
Results
An overall 91 patients were enrolled (control, n = 45; cBMA, n = 46): 82 (90%) completed 2-year clinical follow-up and 75 (82%) completed 1-year MRI. Functional indices significantly improved in both groups by 6 months and were sustained at 1 and 2 years (all P < .05). The control group showed significantly greater evidence of rotator cuff retear according to Sugaya classification on 1-year MRI (57% vs 18%; P < .001). Treatment failed for 7 patients in each group (control, 16%; cBMA, 15%). Conclusion: cBMA-augmented aRCR of isolated supraspinatus tendon tears may result in a structurally superior repair but largely fails to significantly improve treatment failure rates and patient-reported clinical outcomes when compared with aRCR alone. Additional study is warranted to investigate the long-term benefits of improved repair quality on clinical outcomes and repair failure rates. Registration: NCT02484950 (ClinicalTrials.gov identifier).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Sports Medicine, Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, Illinois, USA.
- Coastal Orthopaedics, Bradenton, Florida, USA.
- Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, Illinois, USA.
- Duly Health and Care, Elmhurst, Illinois, USA.
ORCID-Profile: Lakshmanan Sivasundaram, Brian Forsythe
Zitieren
APA
Cole, B. J., Kaiser, J. T., Wagner, K. R., Sivasundaram, L., Otte, R. S., Tauro, T. M., White, G. M., Ralls, M. L., Yanke, A. B., Forsythe, B., Romeo, A. A., & Verma, N. N. (2023). Prospective Randomized Trial of Biologic Augmentation With Bone Marrow Aspirate Concentrate in Patients Undergoing Arthroscopic Rotator Cuff Repair. The American Journal of Sports Medicine, 51(5), 1234-1242. https://doi.org/10.1177/03635465231154601
Vancouver
Cole BJ, Kaiser JT, Wagner KR, Sivasundaram L, Otte RS, Tauro TM, et al. Prospective Randomized Trial of Biologic Augmentation With Bone Marrow Aspirate Concentrate in Patients Undergoing Arthroscopic Rotator Cuff Repair. The American Journal of Sports Medicine. 2023;51(5):1234-1242. doi:10.1177/03635465231154601
BibTeX
@article{Cole2023,
author = {Cole, Brian J and Kaiser, Joshua T and Wagner, Kyle R and Sivasundaram, Lakshmanan and Otte, R Stephen and Tauro, Tracy M and White, Gregory M and Ralls, Michael L and Yanke, Adam B and Forsythe, Brian and Romeo, Anthony A and Verma, Nikhil N},
title = {Prospective Randomized Trial of Biologic Augmentation With Bone Marrow Aspirate Concentrate in Patients Undergoing Arthroscopic Rotator Cuff Repair},
journal = {The American Journal of Sports Medicine},
year = {2023},
volume = {51},
number = {5},
pages = {1234--1242},
doi = {10.1177/03635465231154601}
}
EUVIMED